A clinical trial to study the optimal dose of Hepatitis B vaccine in Human Immunodeficiency Virus (HIV) infected childre
Not Applicable
- Conditions
- Health Condition 1: null- Hepatitis B vaccination in HIV infected children
- Registration Number
- CTRI/2016/01/006495
- Lead Sponsor
- Shahid Akhtar Siddiqui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
HIV infected children (diagnosed as per NACO guidelines)
HBsAg nonreactive
Exclusion Criteria
Received >=1 dose of Hepatitis B vaccine in past
Critically ill/moribund patients
Consent not given
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of standard dose vs. double dose of Hepatitis B vaccination in HIV infected ChildrenTimepoint: 12 weeks after complete vaccination
- Secondary Outcome Measures
Name Time Method To correlate seroprotection after Hepatitis B vaccination in HIV infected children with age, sex of patients, CD4 counts and HAART at vaccinationTimepoint: 12 weeks after complete vaccination